E. Mamounas
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 2
- Oncology top 2%
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
- Genetics top 5%
- Estrogen and related hormone effects 6
- BRCA gene mutations in cancer 3
-
- Advanced Breast Cancer Therapies 4
-
- Advanced Radiotherapy Techniques 2
- Co-authors
- Norman WolmarkJennifer BryantB. FisherRichard G. MargoleseMaureen KavanahRobert H. OishiNikolay V. DimitrovMirsada Begovič
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
E. Mamounas
16 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 1.8k
- Oncology 1.5k
- Pathology and Forensic Medicine 815
- Radiology, Nuclear Medicine and Imaging 468
- Genetics 387
Countries citing papers authored by E. Mamounas
This map shows the geographic impact of E. Mamounas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mamounas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mamounas more than expected).
Fields of papers citing papers by E. Mamounas
This network shows the impact of papers produced by E. Mamounas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mamounas. The network helps show where E. Mamounas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Mamounas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2019 | 29 | |
| 3 | 2018 | 9 | |
| 4 | 2018 | 29 | |
| 5 | 2017 | 3 | |
| 6 | 2017 | 2 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 0 | |
| 9 | 2014 | 1 | |
| 10 | Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831breakdown → | 2014 | 671 |
| 11 | 2014 | 1 | |
| 12 | 2009 | 10 | |
| 13 | 2009 | 0 | |
| 14 | 2007 | 67 | |
| 15 | 2007 | 2 | |
| 16 | 2004 | 20 | |
| 17 | Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18breakdown → | 2001 | 990 |
| 18 | Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialbreakdown → | 1999 | 724 |
| 19 | 1994 | 10 |
About E. Mamounas
E. Mamounas is a scholar working on Cancer Research, Oncology and Genetics, having authored 19 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Estrogen and related hormone effects (6 papers), Advanced Breast Cancer Therapies (4 papers), BRCA gene mutations in cancer (3 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Advanced Radiotherapy Techniques (2 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.5k citations) and Pathology and Forensic Medicine (815 citations). E. Mamounas has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Norman Wolmark, Jennifer Bryant, B. Fisher, Richard G. Margolese, Maureen Kavanah, Robert H. Oishi, Nikolay V. Dimitrov, Mirsada Begovič, Louis Fehrenbacher and Carl G. Kardinal. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.